Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies.

By A. Romero‐Corral, Victor M. Montori, Virend K. Somers, J. Korinek, Randal J. Thomas, T. Allison, F. Mookadam, F. Lopez‐Jimenez. The Lancet, 2006

1,625 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

2016 European Guidelines on cardiovascular disease prevention in clinical practice. (2016, background): “Systematic reviews of patients with CAD or undergoing percutaneous coronary intervention have suggested an ‘obesity paradox’ whereby obesity appears protective.(338,346) This is also the case for HF patients.”
Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. (2015, result): “Such a paradoxical relationship of underweight (high mortality despite low susceptibility) has also been found in patients with coronary heart disease [5], diabetes [6], and renal cell carcinoma [7], and our study was the first to show in patients with HCC.”
Morbidity and mortality associated with obesity. (2017, background): “The Association between BMI and mortality substantially varies between populations and causes of death (52,105) and can change over time (106,107).”